Product Overview
Treviamet 50mg 1000mg Tablets 28s is a medication used to treat type 2 diabetes. It contains a combination of two active ingredients, Metformin Hcl and Sitagliptin, which work together to help control blood sugar levels in the body.

Key Benefits
- Helps lower blood sugar levels in patients with type 2 diabetes
- Reduces the risk of complications related to diabetes
- Improves insulin sensitivity and glucose metabolism
- Convenient once-daily dosing regimen
- May aid in weight loss for some patients

How It Works
Metformin Hcl works by decreasing the amount of sugar produced by the liver and increasing the body's response to insulin. Sitagliptin works by increasing levels of incretin hormones, which help regulate blood sugar levels after meals. Together, these two ingredients work synergistically to improve glycemic control in patients with type 2 diabetes.

Directions for Use
- Take Treviamet 50mg 1000mg Tablets 28s once daily with a meal.
- Swallow the tablet whole with a full glass of water.
- Follow your healthcare provider's instructions for dosage and timing.
- Monitor your blood sugar levels regularly as directed by your doctor.

Precautions
- Do not take this medication if you have a history of kidney disease or other serious medical conditions without consulting your doctor.
- Inform your healthcare provider of any allergies or sensitivities you may have before starting treatment.
- Avoid consuming excessive amounts of alcohol while taking this medication.
- Keep this medication out of reach of children and pets.

Storage Instructions
Store Treviamet 50mg 1000mg Tablets 28s at room temperature away from moisture and heat. Keep the medication in its original packaging to protect it from light and humidity.

Manufacturer Information
Treviamet 50mg 1000mg Tablets 28s is manufactured by Getz Pharmaceuticals, a trusted pharmaceutical company known for producing high-quality medications for various health conditions. Getz Pharmaceuticals is committed to providing safe and effective treatment options for patients worldwide.